A levonorgestrel-releasing intrauterine system for the treatment of dysmenorrhea associated with endometriosis: a pilot study  Paolo Vercellini, M.D.,

Slides:



Advertisements
Similar presentations
Early-stage endometriosis: adhesion and growth of human menstrual endometrium in nude mice Michelle Nisolle, M.D., Ph.D., Françoise Casanas-Roux, B.S.,
Advertisements

Comparison of levonorgestrel intrauterine system versus hysterectomy on efficacy and quality of life in patients with adenomyosis  Ozlem Ozdegirmenci,
Philip M. Sarrel, M. D. , Shannon D. Sullivan, M. D. , Ph. D
Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial  Tasuku Harada,
Continuous versus cyclic use of oral contraceptives after surgery for symptomatic endometriosis: a prospective cohort study  Nikos Vlahos, M.D., Athanasios.
Comparison of contraceptive ring and patch for the treatment of symptomatic endometriosis  Paolo Vercellini, M.D., Giussy Barbara, M.D., Edgardo Somigliana,
Quality of sex life in women with endometriosis and deep dyspareunia
Use of a levonorgestrel-releasing intrauterine system to treat bleeding related to uterine leiomyomas  Vera Grigorieva, MD, Mario Chen-Mok, PhD, Marina.
No difference in cycle pregnancy rate and in cumulative live-birth rate between women with surgically treated minimal to mild endometriosis and women.
Relationship between apoptosis and the number of macrophages in eutopic endometrium from women with and without endometriosis  Donald P Braun, Ph.D.,
Evaluation of the efficacy and safety of dienogest in the treatment of painful symptoms in patients with adenomyosis: a randomized, double-blind, multicenter,
Paolo Vercellini, M.D., Laura Buggio, M.D., Edgardo Somigliana, M.D. 
High soluble CD44 concentration in peritoneal fluid in endometriosis
Endometriosis-associated nerve fibers, peritoneal fluid cytokine concentrations, and pain in endometriotic lesions from different locations  Brett McKinnon,
Qi Shen, M. D. , Ying Hua, M. D. , Ph. D. , Wenxiao Jiang, M. D
Conservative laparoscopic management of urinary tract endometriosis (UTE): surgical outcome and long-term follow-up  Renato Seracchioli, M.D., Mohamed.
Elevated angiogenin levels in the peritoneal fluid of women with endometriosis correlate with the extent of the disorder  Nobuhiro Suzumori, M.D., Xaio.
Norethindrone acetate or dienogest for the treatment of symptomatic endometriosis: a before and after study  Paolo Vercellini, M.D., Benedetta Bracco,
Treatment of endometriosis and chronic pelvic pain with letrozole and norethindrone acetate: a pilot study  Radhika K Ailawadi, M.D., Smeeta Jobanputra,
Lisa L. Amsterdam, M. D. , William Gentry, M. D. , Smeta Jobanputra, M
Postoperative medical treatment of chronic pelvic pain related to severe endometriosis: levonorgestrel-releasing intrauterine system versus gonadotropin-releasing.
Annette Kuhn, M. D. , Christine Bodmer, M. D. , Werner Stadlmayr, M. D
Christine L Cook, M. D. , Yong Siow, Ph. D. , Susan Taylor, B. A
Elizabeth Taylor, M.D., Christina Williams, M.D. 
Surgical treatment of endometriosis: a prospective randomized double-blinded trial comparing excision and ablation  Martin Healey, M.D., W. Catarina Ang,
Effect of prolonged gonadotropin-releasing hormone agonist therapy on the outcome of in vitro fertilization-embryo transfer in patients with endometriosis 
Intraperitoneal and subcutaneous treatment of experimental endometriosis with recombinant human interferon- α-2b in a murine model  José Ma R. Ingelmo,
Prolonged gonadotropin-releasing hormone agonist therapy reduced expression of nitric oxide synthase in the endometrium of women with endometriosis and.
Does colorectal endometriosis alter intestinal functions
Treatment of symptomatic rectovaginal endometriosis with an estrogen–progestogen combination versus low-dose norethindrone acetate  Paolo Vercellini,
Gonadotropin-releasing hormone agonist plus “add-back” hormone replacement therapy for treatment of endometriosis: a prospective, randomized, placebo-controlled,
Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain  William.
Fertility and Sterility  Volume 98, Issue 5, Pages (November 2012)
A danazol-loaded intrauterine device decreases dysmenorrhea, pelvic pain, and dyspareunia associated with endometriosis  Luigi Cobellis, M.D., Sandro.
Deep endometriosis conundrum: evidence in favor of a peritoneal origin
Randomized controlled trial comparing Thermachoice III
Strategies in Pain Management
Induction of endometrial plasminogen activator–inhibitor 1: a possible mechanism contributing to the effect of intrauterine levonorgestrel in the treatment.
Continuous use of an oral contraceptive for endometriosis-associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen  Paolo Vercellini,
Mohamed A.M Hassan, M.Sc., Stephen R Killick, M.D. 
Therapeutic effects of the levonorgestrel-releasing intrauterine system in the treatment of idiopathic menorrhagia  Bilian Xiao, M.D., Shang-Chun Wu,
Macrophage migration inhibitory factor expression in the intrauterine endometrium of women with endometriosis varies with disease stage, infertility status,
From partner's desk to iPad
The Ontario Uterine Fibroid Embolization Trial. Part 2
Paolo Vercellini, M. D. , Silvia Maddalena, M. D. , Olga De Giorgi, M
Spontaneous fertility after expectant or surgical management of rectovaginal endometriosis in women with or without ovarian endometrioma: a retrospective.
Frequency and effect of vaginal bleeding on pregnancy outcome during the first 3 weeks after positive β-hCG test results following IVF-ET  Glen E Hofmann,
Changes in cytokine levels of patients with ovarian endometriosis after treatment with gonadotropin-releasing hormone analogue, ultrasound-guided drainage,
Ettore Cicinelli, M. D. , Louis J Ignarro, M. D. , Pietro Galantino, M
Massimo Tartagni, M. D. , Luca Maria Schonauer, M. D
Katrina M Wyatt, Ph. D. , Paul W Dimmock, Ph. D
Basic Fibroblast Growth Factor: Peritoneal and Follicular Fluid Levels and its Effect on Early Embryonic Development  Emre Seli, M.D., Hulusi B Zeyneloglu,
Imran Pirwany, MD, Togas Tulandi, MD  Fertility and Sterility 
Endometriosis-related infertility: assisted reproductive technology has no adverse impact on pain or quality-of-life scores  Pietro Santulli, M.D., Ph.D.,
Regulation of assisted reproductive technologies in the United States
Decreased levels of interleukin-18 in peritoneal fluid but not in serum of patients with endometriosis  Xinmei Zhang, M.D., Jun Lin, M.D., Yuli Qian,
A randomized controlled pilot study of acupuncture for postmenopausal hot flashes: effect on nocturnal hot flashes and sleep quality  Mary I. Huang, M.S.,
Stephanie A. Beall, M.D., Ph.D., Alan DeCherney, M.D. 
Anne Van Langendonckt, Ph. D. , Françoise Casanas-Roux, Ph. D
Menstrual status and serum leptin levels in anorectic and in menstruating women with low body mass indexes  Costantino Di Carlo, M.D., Giovanni A Tommaselli,
Reliability, feasibility, and safety of minihysteroscopy with a vaginoscopic approach: experience with 6,000 cases  Ettore Cicinelli, M.D., Carlo Parisi,
Olav Istre, M.D., Ph.D., Birgitta Trolle, M.D.  Fertility and Sterility 
Comparison of the effectiveness of single intrauterine insemination (IUI) versus double IUI per cycle in infertile patients  Saeed Alborzi, M.D., Shahdokht.
Association of endometriosis with body size and figure
Reduction of postoperative adhesions by N,O-carboxymethylchitosan: a pilot study  Michael P Diamond, M.D., Anthony Luciano, M.D., D.Alan Johns, M.D., Randall.
Urine vascular endothelial growth factor-A is not a useful marker for endometriosis  Clariss Potlog-Nahari, M.D., Pamela Stratton, M.D., Craig Winkel,
Conception, early pregnancy loss, and time to clinical pregnancy: a population-based prospective study  Xiaobin Wang, M.D., Changzhong Chen, M.D., Lihua.
Soluble HLA-G in the peritoneal fluid of women with endometriosis
The role of T-helper cytokines in human reproduction
Increased pregnancy rates after ultralong postoperative therapy with gonadotropin- releasing hormone analogs in patients with endometriosis  Dagmar Rickes,
Presentation transcript:

A levonorgestrel-releasing intrauterine system for the treatment of dysmenorrhea associated with endometriosis: a pilot study  Paolo Vercellini, M.D., Giorgio Aimi, M.D., Stefania Panazza, M.D., Olga De Giorgi, M.D., Antonella Pesole, M.D., Pier Giorgio Crosignani, M.D.  Fertility and Sterility  Volume 72, Issue 3, Pages 505-508 (September 1999) DOI: 10.1016/S0015-0282(99)00291-5

Figure 1 Baseline (open symbols) and 12-month follow-up (closed symbols) menstrual blood loss (A) and dysmenorrhea (B) scores in 17 women with endometriosis treated with a levonorgestrel-releasing intrauterine system according to, respectively, a pictorial chart devised by Higham et al. (4) and a 100-mm visual analogue scale. Horizontal bars are medians. Vercellini. Levonorgestrel-releasing system. Fertil Steril 1999. Fertility and Sterility 1999 72, 505-508DOI: (10.1016/S0015-0282(99)00291-5)